Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trial
可切除食管鳞状细胞癌新辅助化疗联合或不联合卡瑞利珠单抗:随机3期ESCORT-NEO/NCCES01试验
期刊:Nature Medicine
影响因子:50
doi:10.1038/s41591-024-03064-w
Qin, Jianjun; Xue, Liyan; Hao, Anlin; Guo, Xiaofeng; Jiang, Tao; Ni, Yunfeng; Liu, Shuoyan; Chen, Yujie; Jiang, Hongjing; Zhang, Chen; Kang, Mingqiang; Lin, Jihong; Li, Hecheng; Li, Chengqiang; Tian, Hui; Li, Lin; Fu, Junke; Zhang, Yong; Ma, Jianqun; Wang, Xiaoyuan; Fu, Maoyong; Yang, Hao; Yang, Zhaoyang; Han, Yongtao; Chen, Longqi; Tan, Lijie; Dai, Tianyang; Liao, Yongde; Zhang, Weiguo; Li, Bin; Chen, Qixun; Guo, Shiping; Qi, Yu; Wei, Li; Li, Zhigang; Tian, Ziqiang; Kang, Xiaozheng; Zhang, Ruixiang; Li, Yong; Wang, Zhen; Chen, Xiankai; Hou, Zhiguo; Zheng, Rongrong; Zhu, Wenqing; He, Jie; Li, Yin